Merck's drug for diabetes-related eye disease meets trial goal - Reuters
Merck's drug for diabetes-related eye disease meets trial goal Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMiuAFBVV95cUxQd3JwRm1OSGhUUHQ2V3dvRlBYbGVXb2kzQjBWa2tqbF9STlZXYUpWVmVZa1FFQmI4V0VlbEZDbmp2NUVDdkQtYmUzODBWYTZ2Z01fdF9Zb3NiaDlFU0F3ZVVkMV9scnVOcGdJS2c3bUpfT1JhRUlyNE5LQnNxLXJHMDlab2ZYampFNk1EdjZPVk93dTFEX25mZFF1QThzMUFXc3BjZV90UzEyZjNpWktxTzVraC05dXN6?oc=5" target="_blank">Merck's drug for diabetes-related eye disease meets trial goal</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
Roche's obesity drug boosts blood sugar control, drives 15.5% weight loss in mid-stage trial - Reuters
Roche's obesity drug boosts blood sugar control, drives 15.5% weight loss in mid-stage trial Reuters
September 22, 2026 at 11:25 AMUS FDA approves AbbVie's drug for Parkinson's disease - reuters.com
US FDA approves AbbVie's drug for Parkinson's disease reuters.com
September 25, 2026 at 10:57 PMUS FDA approves Mirum's drug for rare bone disorder - reuters.com
US FDA approves Mirum's drug for rare bone disorder reuters.com
September 25, 2026 at 08:11 PMNovo Nordisk open to direct New York listing, CEO Doustdar tells FT - Reuters
Novo Nordisk open to direct New York listing, CEO Doustdar tells FT Reuters
September 23, 2026 at 04:13 AMWegovy-maker Novo faces calls to map out strategy beyond weight-loss drugs - reuters.com
Wegovy-maker Novo faces calls to map out strategy beyond weight-loss drugs reuters.com
September 21, 2026 at 05:02 AMViking Therapeutics' obesity drug shows durable weight-loss benefit, shares surge - Reuters
Viking Therapeutics' obesity drug shows durable weight-loss benefit, shares surge Reuters
September 22, 2026 at 08:10 PM